BioPhy
PrivateLast Round
Series A
Mar 20, 2025
Total Funding Raised
$11.1M
Company Overview
BioPhy is a healthcare technology company that provides an AI operating system to accelerate the identification and development of promising drug candidates. Its platform uses predictive and generative AI to analyze clinical trial data, forecast outcomes, and provide scientific and clinical guidance to pharmaceutical and life science companies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioPhy Comps
Public and private peers based on sector, stage, and business model.
BioPhy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 20, 2025 | ||||
| Seed | Nov 7, 2023 |
Key People
Founding team and executive leadership
BioPhy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Audere Capital | Seed |
BioPhy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioPhy's valuation, stock price, and market status.
